In parallel with our study, the CHAMPION trial conducted by Widmer et al. involving 29,645 women who underwent vaginal deliveries revealed that carbetocin was non-inferior to oxytocin concerning blood loss (>500 mL) or the requirement for additional uterotonic agents for PPH prevention16. This evidence concerns the gene OXT and pulmonary arterial hypertension.